The current study aims to characterise the association of DACH1 with other cancer relevant biomarkers in the luminal subtype of breast cancer, with the emphasis being in determining its possible role as a clinical classifier of disease outcome and as a prognostic biomarker. The gene discussed is DACH1; the disease is breast cancer.